Bg pattern

GALLIAPHARM 1.11 GBq RADIONUCLIDE GENERATOR

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use GALLIAPHARM 1.11 GBq RADIONUCLIDE GENERATOR

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the Patient

GalliaPharm 1,11GBq Radionuclide Generator

Gallium (68Ga) chloride solution

Read all of this leaflet carefully before you receive this medicine, because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your nuclear medicine specialist who will be supervising the procedure.
  • If you experience any side effects, consult your nuclear medicine specialist, even if they are not listed in this leaflet. See section 4.

Contents of the Package Leaflet

  1. What is GalliaPharm and what is it used for
  2. What you need to know before you start using the gallium (68Ga) chloride solution obtained with GalliaPharm
  3. How to use the gallium (68Ga) chloride solution obtained with GalliaPharm
  4. Possible side effects
  5. Storage of GalliaPharm
  6. Package Contents and Further Information

1. What is GalliaPharm and what is it used for

GalliaPharm is a germanium (68Ge)/gallium (68Ga) radionuclide generator, a device used to obtain a gallium (68Ga) chloride solution. The gallium (68Ga) chloride is a substance whose handling is the responsibility of specialized physicians (nuclear medicine specialists) and pharmacists with the necessary training to work with radioactive materials. The gallium (68Ga) chloride is not intended for direct use in patients, but is used for radiolabeling, a technique in which a substance is labeled (radiolabeled) with a radioactive compound, in this case, 68Ga.

Only medicines that have been specifically developed and approved for radiolabeling with 68Ga are subjected to the radiolabeling procedure with gallium (68Ga) chloride. These radiolabeled medicines can recognize and bind to specific types of body cells and carry the radioactive 68Ga to these body cells. The small amount of radioactivity present in the radiolabeled medicine can be detected from outside the body using special cameras. This can help your doctor with diagnosis. For more information, see the package leaflet of the medicine to be radiolabeled with gallium (68Ga) chloride.

Your nuclear medicine specialist will explain the type of examination to be performed in more detail.

The use of a medicine radiolabeled with 68Ga involves receiving a small amount of radioactivity. Your doctor and nuclear medicine specialist have considered that the clinical benefit you will receive from the procedure with the medicine radiolabeled with 68Ga outweighs the risk of radiation.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you start using the gallium (68Ga) chloride solution obtained with GalliaPharm

The gallium (68Ga) chloride solution obtained with GalliaPharm must not be administered

  • if you are allergic to gallium (68Ga) chloride or to any of the other components of this medicine (listed in section 6).

If you are using a medicine radiolabeled with 68Ga, you should read the information on contraindications included in the package leaflet of the medicine to be radiolabeled.

Warnings and Precautions

For information on special warnings and precautions for the use of medicines radiolabeled with 68Ga, see the package leaflet of the medicine to be radiolabeled.

Children and Adolescents

Tell your nuclear medicine specialist if you or your child are under 18 years old.

Other Medicines and the Gallium (68Ga) Chloride Solution

Tell your nuclear medicine specialist if you are taking, have recently taken, or might take any other medicines, as some medicines may interfere with the interpretation of images by your doctor.

It is not known if the gallium (68Ga) chloride solution can interact with other medicines, as no specific studies have been conducted. You will not receive an injection of gallium (68Ga) chloride, but a medicine that has been combined (radiolabeled) with a gallium (68Ga) chloride solution.

For information on other medicines in combination with the use of medicines radiolabeled with 68Ga, see the package leaflet of the radiolabeled medicine.

Pregnancy, Breast-feeding, and Fertility

If you are pregnant or breast-feeding, think you may be pregnant, or plan to become pregnant, consult your nuclear medicine specialist before you are given medicines radiolabeled with 68Ga.

If there is any possibility that you may be pregnant, if you have a delayed period, or if you are breast-feeding, inform your nuclear medicine specialist before administration of medicines radiolabeled with 68Ga.

In case of doubt, it is important that you consult your nuclear medicine specialist who will be supervising the procedure.

If you are pregnant

Your nuclear medicine specialist will only administer this radiolabeled medicine with 68Ga during pregnancy if the expected benefit outweighs the risk.

If you are breast-feeding

You will be asked to stop breast-feeding. Ask your nuclear medicine specialist when you can restart breast-feeding.

Driving and Using Machines

Effects on the ability to drive and use machines may occur due to the use of medicines radiolabeled with 68Ga. Read the package leaflets of those medicines carefully.

3. How to use the gallium (68Ga) chloride solution obtained with GalliaPharm

The use, handling, and disposal of radiopharmaceuticals are subject to very strict rules. GalliaPharm will only be used in special controlled areas. The production of the gallium (68Ga) chloride solution, as well as the radiolabeling of a specific carrier medicine and the administration of a medicine radiolabeled with 68Ga, will be the exclusive responsibility of properly trained and qualified personnel to use it safely. These personnel will take special care in the safe use of this medicine and will inform you of their actions.

The nuclear medicine specialist supervising the procedure will decide the amount of radiolabeled medicine with 68Ga to be used in your case. This will be the minimum amount necessary to obtain the desired information.

Administration of the Gallium (68Ga) Chloride Solution and Performance of the Procedure

You will not be administered the gallium (68Ga) chloride solution, but another medicine that has been combined (radiolabeled) with a gallium (68Ga) chloride solution.

Duration of the Procedure

Your nuclear medicine specialist will inform you about the usual duration of the procedure with the medicine radiolabeled with 68Ga. For more information, see the package leaflet of the radiolabeled medicine.

After Administration of the Medicine Radiolabeled with Gallium (68Ga) Chloride Solution

Your nuclear medicine specialist will inform you if you need to take special precautions after you have been administered the medicine radiolabeled with 68Ga. Consult your nuclear medicine specialist if you have any doubts.

If You Have Been Administered More Medicine Radiolabeled with Gallium (68Ga) Chloride Solution Than You Should, or If You Have Received a Direct Injection of Gallium (68Ga) Chloride Solution Accidentally

It is unlikely that an overdose or accidental direct injection of a gallium (68Ga) chloride solution will occur, because you will only receive the medicine radiolabeled with 68Ga under the precise control of the nuclear medicine specialist supervising the procedure. Nevertheless, in case of overdose or accidental direct injection, you will receive the necessary attention.

If you have any further questions on the use of this medicine, ask your nuclear medicine specialist who is supervising the procedure.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible Side Effects

Like all medicines, the medicine radiolabeled with 68Ga can cause side effects, although not everybody gets them.

After administration of the medicine radiolabeled with 68Ga, you will be administered low amounts of ionizing radiation with minimal risk of cancer and congenital anomalies.

For more information on possible side effects, see the package leaflet of the radiolabeled medicine.

Reporting of Side Effects

If you experience any side effects, consult your nuclear medicine specialist, even if they are not listed in this leaflet. You can also report them directly through the national reporting system included in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of GalliaPharm

You will not need to store this medicine. This medicine is stored under the responsibility of the specialist in suitable premises. The storage of radiopharmaceuticals will be carried out in accordance with national regulations on radioactive materials.

This information is intended only for the specialist.

The radionuclide generator must not be used after the expiry date stated on the container after «EXP».

Do not dismantle the box.

The gallium (68Ga) chloride solution obtained with GalliaPharm must be used immediately.

6. Package Contents and Further Information

Composition of GalliaPharm

  • The active substances are germanium (68Ge) and gallium (68Ga) chloride dissolved in sterile ultrapure hydrochloric acid at a concentration of 0.1 mol/l. The germanium (68Ge) is irreversibly trapped within the radionuclide generator and decays into its daughter nuclide (68Ga), which is obtained from the generator as gallium (68Ga) chloride.
  • The other components are: Titanium dioxide (matrix)

Sterile ultrapure hydrochloric acid at a concentration of 0.1 mol/l (eluate solution)

A radionuclide generator is supplied with:

  1. 1 PP container containing the eluate, 250 ml of sterile ultrapure hydrochloric acid at a concentration of 0.1 mol/l (including a separate hanger for PP vials; PP: polypropylene)
  2. 1 ventilated puncture device (ABS: acrylonitrile butadiene styrene/PE: polyethylene)
  3. 2 1/16” male LUER adapters (PEEK)
  4. 2 tubes (60 cm) (PEEK)
  5. 1 tube (40 cm) (PEEK)
  6. 1 tube (20 cm) (PEEK)
  7. 3 1/16” 10-32 Fingertight connectors (PEEK)
  8. 1 1/16” M6 Fingertight connector (PEEK)
  9. 1 key (TPX: polymethylpentene/HDPE: high-density polyethylene)
  10. 1 male LUER union (PP)

Appearance of the Product and Package Contents

You will not receive or handle this medicine.

Marketing Authorisation Holder and Manufacturer

Eckert & Ziegler Radiopharma GmbH

Robert-Rössle-Str. 10

13125 Berlin

Germany

Date of Last Revision of this Leaflet:

Other Sources of Information

Detailed information on this medicine is available on the European Medicines Agency website: http://www.ema.europa.eu.

The package leaflet of this medicine can be found in all languages of the European Union/European Economic Area on the European Medicines Agency website.

--------------------------------------------------------------------------------------------------------------

This information is intended only for healthcare professionals:

The full summary of product characteristics of GalliaPharm is provided in a separate document in the product packaging, with the aim of providing healthcare professionals with additional scientific and practical information on the administration and use of this radiopharmaceutical.

See the summary of product characteristics or package leaflet.

Online doctors for GALLIAPHARM 1.11 GBq RADIONUCLIDE GENERATOR

Discuss questions about GALLIAPHARM 1.11 GBq RADIONUCLIDE GENERATOR, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (195)
Doctor

Taisiia Proida

Family medicine 7 years exp.

Taisiia Proida is a general practitioner with a specialization in mental health and a cognitive behavioral therapist (CBT), a member of the European Psychiatric Association. She offers online consultations for adults aged 18 and over, combining evidence-based medicine with an individualised approach to mental health care. She specialises in consultations and ongoing support for a wide range of mental health concerns, including: 

  • Mood disorders: depression, bipolar disorder, postpartum depression.
  • Anxiety disorders: generalised anxiety, OCD, panic attacks, phobias.
  • Post-traumatic stress disorder (PTSD) and complex PTSD.
  • Attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Assessment is provided only after an initial psychiatric evaluation and during a follow-up appointment.
  • Personality disorders and emotional instability.
  • Cyclothymia and mood fluctuations.
  • Schizophrenia spectrum and related conditions.

Dr. Proida combines clinical expertise with an empathetic approach, offering structured support based on evidence-based practices. Her work integrates CBT techniques with medical management, with a focus on anxiety and depressive disorders. She works with clients from different countries and cultural backgrounds, adapting her communication style and recommendations to individual needs. With experience in international clinical trials (Pfizer, Merck), she values clarity, trust, and collaborative partnership in patient care.

5.0 (111)
Doctor

Sergey Ilyasov

Psychiatry 7 years exp.

Dr Sergey Ilyasov is an experienced neurologist and qualified psychiatrist who provides online consultations for adults and adolescents. Combining deep neurological expertise with a modern psychiatric approach, he ensures comprehensive diagnostics and effective treatment for a wide range of conditions affecting both physical and mental health.

Dr. Ilyasov helps patients in the following cases:

  • Chronic headaches (migraine, tension-type headache), back pain, neuropathic pain, dizziness, numbness in limbs, coordination disorders.
  • Anxiety disorders (panic attacks, generalized anxiety disorder), depression (including atypical and treatment-resistant forms), sleep disturbances (insomnia, hypersomnia, nightmares), stress, burnout.
  • Chronic pain syndromes and psychosomatic symptoms (e.g., irritable bowel syndrome related to stress, vegetative-vascular dystonia).
  • Behavioral disorders and concentration difficulties in adolescents (including ADHD, autism spectrum disorders), nervous tics.
  • Memory impairments, phobias, obsessive-compulsive disorder (OCD), emotional swings, and support for post-traumatic stress disorder (PTSD).

Thanks to his dual specialization in neurology and psychiatry, Dr Sergey Ilyasov offers integrated and evidence-based care for complex conditions requiring a multidisciplinary approach. His consultations focus on accurate diagnosis, development of an individualized treatment plan (including pharmacotherapy and psychotherapeutic methods), and long-term support adapted to each patient's unique needs.

Book an online consultation with Dr. Sergey Ilyasov to receive qualified assistance and improve your well-being today.

Camera Book a video appointment
€106
5.0 (2)
Doctor

Alexander Nazarchuk

Allergology 7 years exp.

Dr. Alexander Nazarchuk is a physician specialising in allergology and internal medicine. He provides online consultations for adults, following the principles of evidence-based medicine — no outdated treatments or unnecessary tests, with clear explanations and a personalised approach. He helps patients with a wide range of allergic and therapeutic conditions, from common day-to-day complaints to complex cases involving allergies, gastrointestinal issues, cardiovascular concerns, respiratory symptoms, and more.

You can consult Dr. Nazarchuk for:

  • Test interpretation and guidance on diagnostic plans.
  • Allergic rhinitis, hay fever, bronchial asthma (including severe cases).
  • Food and drug allergies, skin rashes, angioedema.
  • Atopic dermatitis, urticaria, contact allergies.
  • Allergen-specific immunotherapy (AIT) – initiation and ongoing management.
  • Abdominal pain, bloating, changes in bowel habits, nausea, heartburn.
  • High blood pressure and adjustment of baseline antihypertensive therapy.
  • Hyperlipidaemia and elevated cholesterol.
  • Cough, nasal congestion, fever, sore throat.
  • Anaemia, including iron deficiency and related conditions.
  • Other issues related to allergology and internal medicine.

During consultations, Dr. Nazarchuk takes a thorough, structured approach — analysing symptoms, identifying potential causes, and helping patients make informed decisions. Whether treatment, further investigation, or monitoring is needed, he explains each step clearly so you understand your health and how best to manage it.

Camera Book a video appointment
€66
5.0 (5)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques. For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance. Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults. In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions. Patients commonly seek his care for: 

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns

Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.

Camera Book a video appointment
€86
0.0 (0)
Doctor

Marta Reguero Capilla

Allergology 8 years exp.

Dr Marta Reguero Capilla is an allergist and immunologist who works with both adults and children. She specialises in the diagnosis, treatment, and ongoing management of allergic and immune-related conditions through online consultations. In her practice, Dr Reguero Capilla helps patients understand the causes of their symptoms, review test results, and choose appropriate treatment or monitoring strategies. Her consultations are suitable both for first-time assessments and for follow-up care over time. Patients commonly consult Dr Marta Reguero Capilla for: 

  • allergic rhinitis, seasonal allergies, and perennial allergy symptoms;
  • allergic conditions in adults and children;
  • bronchial asthma and allergy-related respiratory symptoms;
  • urticaria (acute and chronic) and angioedema;
  • food allergies and reactions to foods, additives, or medications;
  • atopic dermatitis, allergic rashes, and persistent itching;
  • unexplained or recurrent allergic reactions;
  • interpretation of laboratory tests, allergy testing, and immunology results;
  • immune system concerns, frequent infections, and reduced immune response;
  • ongoing medical follow-up and treatment adjustment.

Dr Reguero Capilla works in a structured and attentive manner, explaining medical decisions clearly and helping patients make informed choices about their own health or their child’s care. When clinically appropriate, she may provide recommendations for further tests or referrals that patients can use within Spanish medical networks, including Sanitas and DKV, in accordance with the terms and conditions of those services.

Camera Book a video appointment
€66
...
5

Get GALLIAPHARM 1.11 GBq RADIONUCLIDE GENERATOR Prescription Online

1

Fill in a 2-min form

Tell us your symptoms, history, and what medicine you're requesting.

2

Pick a doctor or let us assign

Choose a specialist or we'll match you with the next available doctor.

3

Doctor reviews your case

Usually within 30 minutes. They may ask follow-up questions via chat.

4

Collect from any pharmacy

Electronic prescription sent to your email — valid across Spain.

Frequently Asked Questions

Is a prescription required for GALLIAPHARM 1.11 GBq RADIONUCLIDE GENERATOR?

GALLIAPHARM 1.11 GBq RADIONUCLIDE GENERATOR requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.

Who manufactures GALLIAPHARM 1.11 GBq RADIONUCLIDE GENERATOR?

GALLIAPHARM 1.11 GBq RADIONUCLIDE GENERATOR is manufactured by Eckert & Ziegler Radiopharma Gmbh. Pharmacy brands and packaging may differ depending on the distributor.

Which doctors can assess the use of GALLIAPHARM 1.11 GBq RADIONUCLIDE GENERATOR online?

Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether GALLIAPHARM 1.11 GBq RADIONUCLIDE GENERATOR is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.

How to buy GALLIAPHARM 1.11 GBq RADIONUCLIDE GENERATOR in Spain?

Spain has a well-developed healthcare infrastructure across major cities such as Madrid, Barcelona, Valencia, and Seville. Pharmacies are widely available and operate under strict regulations, ensuring access to prescribed medications.

You can buy GALLIAPHARM 1.11 GBq RADIONUCLIDE GENERATOR in Madrid, Barcelona, Seville, or Valencia at any local pharmacy with a valid prescription.

To obtain a prescription, you can use Oladoctor:

What are the alternatives to GALLIAPHARM 1.11 GBq RADIONUCLIDE GENERATOR?

Other medicines with the same active substance () include GALLIAPHARM 0.74 - 1.85 GBq RADIONUCLIDE GENERATOR, NORCOLESTEROL IODINATED (131 I) CIS BIO INTERNATIONAL 7.5-15 MBq/ml INJECTABLE SOLUTION, ADREVIEW 74 MBq/ml INJECTABLE SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.

bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media